Susquehanna International Group’s CalciMedica CALC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$16.6K Buy
+30,716
New +$62.3K ﹤0.01% 12888
2023
Q1
Sell
-3,204
Closed -$22.4K 12619
2022
Q4
$22.4K Sell
3,204
-1,313
-29% -$14.7K ﹤0.01% 11728
2022
Q3
$59K Buy
4,517
+3,715
+463% +$52.6K ﹤0.01% 12096
2022
Q2
$12K Buy
+802
New +$10.9K ﹤0.01% 12475
2021
Q4
Sell
-3,499
Closed -$136K 13145
2021
Q3
$162K Sell
3,499
-15,700
-82% -$883K ﹤0.01% 11724
2021
Q2
$1.46M Buy
+19,199
New +$1.26M ﹤0.01% 6711

Other funds holding CALC

Susquehanna International Group's CALC Position: Q1 2026 in Review

Susquehanna International Group opened a new position in CalciMedica (CALC) in Q1 2026: 30,716 shares worth $16.6K. The stake represents ﹤0.01% of the portfolio and ranks #12888 among its holdings. This is a return to the name: Susquehanna International Group previously reported a position in CALC as recently as Q4 2022.

Susquehanna International Group first reported a position in CALC in Q2 2021 and has held it in 6 quarters since. The position peaked at $1.46M in Q2 2021. 27 funds tracked by Wall St. Rank hold CALC as of Q1 2026.

  • Susquehanna International Group held 30,716 shares of CalciMedica worth $16.6K as of Q1 2026.
  • CalciMedica was a new Susquehanna International Group position in Q1 2026.
  • CalciMedica made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #12888 holding.
  • Susquehanna International Group first reported a position in CalciMedica in Q2 2021 and has held it in 6 quarters since.
  • Susquehanna International Group's CalciMedica position peaked at $1.46M in Q2 2021.
  • 27 funds tracked by Wall St. Rank held CalciMedica as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.